CBD Reduced Anxiety and Brain Inflammation in Obese Aged Rats

In aged rats fed an obesogenic diet, CBD at 15 mg/kg daily reduced anxiety-like behavior, lowered circulating endotoxin levels, and decreased brain inflammation markers.

Jantsch, Jeferson et al.·Brain·2025·lowanimal study
RTHC-06737Animal studylow2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
animal study
Evidence
low
Sample
Not reported

What This Study Found

Cafeteria diet increased anxiety-like behaviors, circulating LPS (endotoxemia), and prefrontal cortex IL-6 in 18-month-old rats. CBD (15 mg/kg/day orally) reduced anxiety in the open field test, decreased circulating LPS, and reduced prefrontal cortex IL-6, TNF-alpha, and TLR4 expression. The obesogenic diet also disrupted endocannabinoid levels (2-AG and anandamide) and altered CB1/CB2 receptor expression in the brain.

Key Numbers

CBD dose: 15 mg/kg/day orally. Rats aged 18 months. CBD reduced circulating LPS, IL-6, TNF-alpha, and TLR4 in prefrontal cortex. Cafeteria diet reduced 2-AG and anandamide and altered CB1/CB2 expression.

How They Did This

Four groups of 18-month-old male Wistar rats: control+vehicle, control+CBD, cafeteria diet+vehicle, cafeteria diet+CBD. Diets for 8 weeks, then oral CBD (15 mg/kg/day) or vehicle concurrently for additional weeks. Behavioral tests, cytokine analysis, endocannabinoid measurements, and receptor expression assessed.

Why This Research Matters

Obesity and aging together create a neuroinflammatory state that drives anxiety and cognitive decline. Finding that CBD can address this intersection is relevant given the aging population and obesity epidemic.

The Bigger Picture

The study connects several dots: obesity causes gut-derived endotoxemia, which drives brain inflammation, which disrupts the endocannabinoid system, which increases anxiety. CBD appears to intervene at multiple points in this cascade.

What This Study Doesn't Tell Us

Male rats only. Cafeteria diet model is extreme compared to typical human diets. CBD dose relative to human equivalent dosing needs consideration. 18-month-old rats represent late middle age, not elderly. No long-term safety data.

Questions This Raises

  • ?Would CBD show the same anti-anxiety effects in aged female rats with diet-induced obesity?
  • ?Could CBD prevent rather than treat obesity-induced neuroinflammation if started earlier?

Trust & Context

Key Stat:
CBD at 15 mg/kg daily reduced anxiety and brain inflammation in 18-month-old obese rats
Evidence Grade:
Single animal study with comprehensive outcome measures but limited by male-only design and extreme dietary model.
Study Age:
2025 publication.
Original Title:
Cannabidiol attenuates diet-induced metabolic endotoxemia, neuroinflammation, and anxiety-like behaviors in male aged rats.
Published In:
Brain, behavior, and immunity, 130, 106121 (2025)
Database ID:
RTHC-06737

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkTHC

Cite This Study

RTHC-06737·https://rethinkthc.com/research/RTHC-06737

APA

Jantsch, Jeferson; Rodrigues, Fernanda da Silva; Wickert, Fernanda; Fraga, Gabriel de Farias; Dias, Victor Silva; Bitencourt, Yasmin Meireles; Giovenardi, Márcia; Guedes, Renata Padilha. (2025). Cannabidiol attenuates diet-induced metabolic endotoxemia, neuroinflammation, and anxiety-like behaviors in male aged rats.. Brain, behavior, and immunity, 130, 106121. https://doi.org/10.1016/j.bbi.2025.106121

MLA

Jantsch, Jeferson, et al. "Cannabidiol attenuates diet-induced metabolic endotoxemia, neuroinflammation, and anxiety-like behaviors in male aged rats.." Brain, 2025. https://doi.org/10.1016/j.bbi.2025.106121

RethinkTHC

RethinkTHC Research Database. "Cannabidiol attenuates diet-induced metabolic endotoxemia, n..." RTHC-06737. Retrieved from https://rethinkthc.com/research/jantsch-2025-cannabidiol-attenuates-dietinduced-metabolic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.